IQVIA, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
IQVIA, Inc. - overview
Established
1982
Location
Danbury, CT, US
Primary Industry
Biotechnology
About
Founded in 1982 and based in North Carolina, US, IQVIA, Inc. (formerly Quintiles IMS Holdings Inc) was formed through the merger between IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. In May 2016, IMS Health Inc.
, a portfolio company of TPG and Leonard Green & Partners, agreed to merge with Quintiles Transnational Corporation, a portfolio company of Bain, 3i, and TPG, to form IQVIA, Inc. for USD 9 billion and the deal was completed ion October 2016. The company is listed on the NYSE under the ticker symbol IQV. The company provides clinical research, biopharmaceutical development, market intelligence, and other human data science services to the pharmaceutical and healthcare sectors.
The company operates Research and Development division and Technology and Analytics division. The company's R&D division provides late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The company's technology & analytics segment provides information and technology services for clinical and virtual trials. The company's IQVIA Connected Intelligence™ helps companies in clinical development for medical treatments.
Current Investors
Two Sigma Investments
Primary Industry
Biotechnology
Sub Industries
Consulting Services, Bioinformatics, Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.iqvia.com
Verticals
Artificial Intelligence, HealthTech, RegTech
Total Amount Raised
Subscriber access only
IQVIA, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Illumimera | - | ||||||||
| Add-on, Trade Sale | Completed | Pharmaspectra US, LLC | - | ||||||||
| Add-on | Completed | Q2 Solutions | - | ||||||||
| Private Placement/Follow on | Completed | IQVIA, Inc. | - | ||||||||
| Private Placement/Follow on | Completed | IQVIA, Inc. | - |
Displaying 1 - 5 of 18
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.